|
NCOA6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.564800E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.484300E-03 |
| Normal-vs-Stage2 |
6.813200E-01 |
| Normal-vs-Stage3 |
8.988300E-04 |
| Normal-vs-Stage4 |
3.023600E-03 |
| Stage1-vs-Stage2 |
2.515600E-02 |
| Stage1-vs-Stage3 |
2.095800E-01 |
| Stage1-vs-Stage4 |
5.584400E-01 |
| Stage2-vs-Stage3 |
7.701000E-03 |
| Stage2-vs-Stage4 |
2.271700E-02 |
| Stage3-vs-Stage4 |
7.252600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.993200E-04 |
| Normal-vs-AfricanAmerican |
1.043360E-01 |
| Normal-vs-Asian |
9.480600E-03 |
| Caucasian-vs-AfricanAmerican |
5.147600E-01 |
| Caucasian-vs-Asian |
8.496600E-01 |
| AfricanAmerican-vs-Asian |
6.186200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.576200E-03 |
| Normal-vs-Female |
3.064400E-03 |
| Male-vs-Female |
9.640400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.181950E-02 |
| Normal-vs-Age(41-60Yrs) |
5.834700E-04 |
| Normal-vs-Age(61-80Yrs) |
4.690100E-02 |
| Normal-vs-Age(81-100Yrs) |
9.661300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.886400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.152600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.233200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.997400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.436800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.022400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.520640E-01 |
| Classical-VS-Follicular |
1.077180E-01 |
| Classical-VS-Other |
5.824000E-01 |
| Classical-VS-Normal |
2.455000E-03 |
| Tall-VS-Follicular |
1.405900E-02 |
| Tall-VS-Other |
8.488800E-01 |
| Tall-VS-Normal |
8.216900E-04 |
| Follicular-VS-Other |
3.616400E-01 |
| Follicular-VS-Normal |
2.783200E-01 |
| Other-VS-Normal |
8.426400E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.629860E-02 |
| Normal-vs-N1 |
7.032000E-04 |
| N0-vs-N1 |
1.360810E-01 |
|
|
